A detailed history of Balanced Rock Investment Advisor transactions in Eli Lilly & CO stock. As of the latest transaction made, Balanced Rock Investment Advisor holds 334 shares of LLY stock, worth $302,891. This represents 0.25% of its overall portfolio holdings.

Number of Shares
334
Previous 362 7.73%
Holding current value
$302,891
Previous $282 Million 7.38%
% of portfolio
0.25%
Previous 0.24%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $20,296 - $25,453
-28 Reduced 7.73%
334 $302 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $82,315 - $110,126
-139 Reduced 27.74%
362 $282 Million
Q4 2023

Feb 13, 2024

BUY
$525.19 - $619.13 $263,120 - $310,184
501 New
501 $292 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $862B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Balanced Rock Investment Advisor Portfolio

Follow Balanced Rock Investment Advisor and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balanced Rock Investment Advisor, based on Form 13F filings with the SEC.

News

Stay updated on Balanced Rock Investment Advisor with notifications on news.